By Tali Rackner
Minneapolis, April 17 – Bank of Montreal priced $32,000 of 7.2% autocallable cash-settled notes with fixed interest payments due March 29, 2018 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
Interest is payable monthly.
The notes will be called at par if the fund closes above its 110% call level on any monthly review date.
The payout at maturity will be par unless the fund finishes below its initial level and ever closes below its 80% trigger level during the life of the notes, in which case investors be fully exposed to any losses.
BMO Capital Markets Corp. is the agent.
| Issuer: | Bank of Montreal
|
| Issue: | Autocallable cash-settled notes with fixed interest payments
|
| Underlying ETF: | iShares Nasdaq Biotechnology ETF
|
| Amount: | $32,000
|
| Maturity: | March 29, 2018
|
| Coupon: | 7.2%, payable monthly
|
| Price: | Par of $1,000
|
| Payout at maturity: | Par unless the fund finishes below its initial level and ever closes below the trigger level during the life of the notes, in which case investors will be fully exposed to any losses
|
| Call: | At par plus the coupon if the fund finishes above the 110% call level on any monthly call date
|
| Initial price: | $292.01
|
| Trigger price: | $233.61, 80% of initial price
|
| Pricing date: | March 28
|
| Settlement date: | March 31
|
| Agent: | BMO Capital Markets Corp.
|
| Fees: | 0.6%
|
| Cusip: | 06367TTL4
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
